Progression of Bone Disease Without Deterioration of Hematological Parameters in a Child With Gaucher Disease During Low-Dose Glucocerebrosidase Therapy.

Journal of Nippon Medical School
doi 10.1272/jnms1923.61.633
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medical Association of Nippon Medical School

Related search

Glucocerebrosidase Deficiency Dramatically Impairs Human Bone Marrow Haematopoiesis in an in Vitro Model of Gaucher Disease

British Journal of Haematology
Hematology
2010English

Glucocerebrosidase 2 Gene Deletion Rescues Type 1 Gaucher Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Treatment of Cushing's Disease With Low Dose Radiation Therapy.

BMJ
1984English

High Throughput Screening for Small Molecule Therapy for Gaucher Disease Using Patient Tissue as the Source of Mutant Glucocerebrosidase

PLoS ONE
Multidisciplinary
2012English

AB120. Cholelithiasis in a Filipino Child With Chronic Neuronopathic Gaucher Disease: Report of a Case

Annals of Translational Medicine
Medicine
2017English

Gaucher Disease: Isolation and Comparison of Normal and Mutant Glucocerebrosidase From Human Spleen Tissue.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1978English

Mechanism of Glucocerebrosidase Activation and Dysfunction in Gaucher Disease Unraveled by Molecular Dynamics and Deep Learning

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Mood Changes Associated With "End-Of-Dose Deterioration" in Parkinson's Disease: A Controlled Study.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1986English

Arimoclomol as a Potential Therapy for Neuronopathic Gaucher Disease

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy